(August 24, 2022, 1:00 PM EDT) -- PHILADELPHIA — The Pennsylvania federal judge overseeing the Suboxone antitrust multidistrict litigation on Aug. 22 denied motions by defendant Indivior Inc. for summary judgment on claims by direct purchasers and state attorneys general who allege the company used a new formulation of its opioid treatment drug to block the marketing of generic versions....